Abnormal response to IL-5 in B-cell chronic lymphocytic leukemia

Leuk Res. 1993 Sep;17(9):777-83. doi: 10.1016/0145-2126(93)90112-x.

Abstract

In B-cell chronic lymphocytic leukemia, neoplastic B-lymphocytes are arrested in development. Since interleukins are essential for B-cell differentiation, we examined whether B-CLL cells were capable of responding normally to interleukins. Purified B-lymphocytes from B-CLL patients and controls were compared for their ability to proliferate and differentiate after stimulation with MCAT or SAC plus rhIL-2 or rhIL-5. When rhIL-5 was added to MCAT-stimulated cells, 8 of 10 controls showed a substantial increase in IgM production, compared with only 1 of 10 B-CLL patients. Lack of IL-5 responsiveness could provide insight into the arrested B-lymphocyte development of some B-CLL patients.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Cell Division / drug effects
  • Humans
  • Immunoglobulin M / biosynthesis
  • Interleukin-2 / pharmacology
  • Interleukin-5 / pharmacology*
  • Leukemia, Lymphocytic, Chronic, B-Cell / immunology
  • Leukemia, Lymphocytic, Chronic, B-Cell / pathology*
  • Mitogens / pharmacology
  • Recombinant Proteins / pharmacology
  • Tumor Cells, Cultured

Substances

  • Immunoglobulin M
  • Interleukin-2
  • Interleukin-5
  • Mitogens
  • Recombinant Proteins